Trial Profile
Tolerability, Safety and Treatment Response of Flexible Doses of Paliperidone ER acutely exacerbated subjects with schizofrenia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms PERTAIN
- Sponsors Janssen-Cilag
- 05 Oct 2021 This trial has been completed in Lithuania, Germany, Italy, France according to European Clinical Trials Database record. (2009-05-12).
- 05 Oct 2021 Status changed from recruiting to completed.
- 12 Jul 2011 This trial is completed in Italy, Lithuania, Germany.